The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
Cancer Research - United States
doi 10.1158/0008-5472.can-07-5809
Full Text
Open PDFAbstract
Available in full text
Date
June 15, 2008
Authors
Publisher
American Association for Cancer Research (AACR)